Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Ryerson University

$25,000.00

Wrinkled non-spherical microparticles as a new microcarrier for cell culture applications in Sanofi Pasteur

FY 2017-18

Summary
Mammalian cells used to produce various vaccines in bioreactors are typically grown on a support matrixtermed a microcarrier, which can be made of a number of different materials including DEAE-dextran, glass,polystyrene plastic, acrylamide, collagen, and alginate. Commercial microcarriers are only available in smoothsurface, spherical forms. Spheres have the smallest surface-area-to-volume ratio, and therefore the least surfacespace available for cells to attach for a given volume. In addition to their spherical shape, the smooth surface ofavailable microcarriers makes it difficult to increase the surface area for cell culture capacity improvement.Another challenge in current microcarrier-based cell culture is that the microcarrier surface needs to bechemically modified prior to cell attachment and detachment (recovery) - often involving expensive enzymes.The Hwang group at Ryerson has developed a technique that can produce microcarriers with designed shapesand tuneable surface wrinkles that can significantly increase their surface area. When used for cell culture,these microcarriers can greatly improve cell attaching capacity. In addition, the microcarrier surface is notchemically modified, which simplifies the cell attaching and recovery process without using enzymes.Sanofi Pasteur is a world leading vaccine manufacturing company, and its head office in Toronto has Canada'slargest vaccine R&D facility. Sanofi manufactures several vaccines through mammalian cell culture usingmicrocarriers. This Engage grant will enable Sanofi and the Ryerson team to begin working towardssuccessfully integrating these non-spherical-microcarrier-based technologies into their vaccine production. As aresult, cell culture efficiency and vaccine production at Sanofi can be significantly improved in the future.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
508822-2017
Name nom
Hwang, DaeKun
Department département
Chemical Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Wrinkled non-spherical microparticles as a new microcarrier for cell culture applications in Sanofi Pasteur
Keyword
NSERC
Application summary
Mammalian cells used to produce various vaccines in bioreactors are typically grown on a support matrixtermed a microcarrier, which can be made of a number of different materials including DEAE-dextran, glass,polystyrene plastic, acrylamide, collagen, and alginate. Commercial microcarriers are only available in smoothsurface, spherical forms. Spheres have the smallest surface-area-to-volume ratio, and therefore the least surfacespace available for cells to attach for a given volume. In addition to their spherical shape, the smooth surface ofavailable microcarriers makes it difficult to increase the surface area for cell culture capacity improvement.Another challenge in current microcarrier-based cell culture is that the microcarrier surface needs to bechemically modified prior to cell attachment and detachment (recovery) - often involving expensive enzymes.The Hwang group at Ryerson has developed a technique that can produce microcarriers with designed shapesand tuneable surface wrinkles that can significantly increase their surface area. When used for cell culture,these microcarriers can greatly improve cell attaching capacity. In addition, the microcarrier surface is notchemically modified, which simplifies the cell attaching and recovery process without using enzymes.Sanofi Pasteur is a world leading vaccine manufacturing company, and its head office in Toronto has Canada'slargest vaccine R&D facility. Sanofi manufactures several vaccines through mammalian cell culture usingmicrocarriers. This Engage grant will enable Sanofi and the Ryerson team to begin working towardssuccessfully integrating these non-spherical-microcarrier-based technologies into their vaccine production. As aresult, cell culture efficiency and vaccine production at Sanofi can be significantly improved in the future.